Join host Melissa Middeldorp and her guests Marco Perez and Kristie Coleman for this installment of The Lead!
| This multicenter randomized controlled trial evaluated whether smartwatch-based rhythm monitoring improves detection of previously undiagnosed atrial fibrillation (AF) in cardiology outpatients aged ≥65 years with elevated stroke risk. A total of 437 participants were randomized to either 6-month monitoring with an Apple Watch integrating photoplethysmography-based irregular rhythm detection and single-lead ECG confirmation, supported by a telemonitoring adjudication pathway, or to standard care. The primary endpoint of new AF occurred significantly more often in the intervention group than in controls (9.6% vs 2.3%; HR 4.40), with many cases asymptomatic and detected earlier through wearable monitoring. All diagnosed patients were initiated on anticoagulation, and major adverse cardiovascular events were similar between groups. Overall, the study demonstrates that prolonged smartwatch-based screening embedded within a clinical workflow substantially increases AF detection in a high-risk population, highlighting the feasibility of wearable-enabled case finding while underscoring ongoing questions regarding clinical outcomes and optimal implementation. |
Learning Objectives
- Describe the design and key findings of a randomized trial evaluating smartwatch-based screening for atrial fibrillation in older patients at elevated stroke risk.
- Discuss the clinical implications, limitations, and broader evidence context of wearable-enabled atrial fibrillation detection within contemporary screening strategies.
Article Authors
Nicole J. van Steijn, Isabel S. Blommestijn, Sebastiaan Blok, Shari Pepplinkhuizen, Aernout Somsen, Reinoud E. Knops, Laura Breukel, Jan G.P. Tijssen, Igor I. Tulevski, Philip M. Croon, Michiel M. Winter
Podcast Contributors
Melissa E. Middeldorp, MPH, PhD
Kristie Coleman, MPH, RN
Marco Perez, MD
Speaker and Article Information: Download
Listen on HRS365
Listen on iHeart
Listen on Spotify
Listen on Apple Podcasts
Topic
- The Lead
Related Resources
Safety Alerts
Device–Device Interaction Between Medtronic Sphere-9™ Ablation Catheter and Biotronik ICD/CRT-D Systems
The Heart Rhythm Society (HRS) is notifying clinicians of a reported device–device interaction between the Medtronic Sphere-9™ ablation catheter and Biotronik implantable cardioverter-defibrillator (ICD) and…
April 16, 2026
The Lead
Podcasts
The Lead Episode 143: A Discussion of The Empirical Evidence in the Successful Anatomical Ablation of Idiopathic LV Summit Ventricular Arrhythmias
In this discussion, Dr. Deep Chandh Raja, MBBS, MD, PhD, is joined…
April 9, 2026
The Lead
Podcasts
The Lead Episode 142: A Discussion of Class 1c Antiarrhythmic Therapy Following PCI in New Onset Atrial Fibrillation: Safety and Clinical Outcomes from a Nationwide Cohort
Join an expert-led discussion exploring the safety and clinical outcomes of Class…
April 2, 2026